Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Exagen Inc (XGN)

Exagen Inc (XGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Exagen Inc 1261 LIBERTY WAY VISTA CA 92081 USA

www.exagen.com Employees: 209 P: 760-560-1501

Sector:

Medical

Description:

Exagen Inc. is engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases. It developed and commercialises testing products under AVISE brand. Exagen Inc. is based in Vista, California.

Key Statistics

Overview:

Market Capitalization, $K 74,335
Enterprise Value, $K 72,535
Shares Outstanding, K 22,663
Float, K 19,807
% Float 87.40%
Short Interest, K 1,793
Short Float 7.91%
Days to Cover 2.65
Short Volume Ratio 0.42
% of Insider Shareholders 12.60%
% of Institutional Shareholders 75.25%

Financials:

Annual Sales, $ 55,640 K
Annual Net Income, $ -15,120 K
Last Quarter Sales, $ 17,240 K
Last Quarter Net Income, $ -7,090 K
EBIT, $ -12,480 K
EBITDA, $ -10,600 K

Growth:

1-Year Return -23.19%
3-Year Return 26.15%
5-Year Return -81.86%
5-Year Revenue Growth 37.76%
5-Year Earnings Growth 90.19%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 11/04/25
Next Earnings Date 03/10/26 [--]
Earnings Per Share ttm -0.77
EPS Growth vs. Prev Qtr -5.56%
EPS Growth vs. Prev Year 32.14%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

XGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -113.48%
Return-on-Assets % -30.28%
Profit Margin % -27.17%
Debt/Equity 1.26
Price/Sales 1.05
Price/Cash Flow N/A
Price/Book 4.02
Book Value/Share 0.81
Interest Coverage -5.77
60-Month Beta 1.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar